CHD1 deletion
|
Prostate Cancer
|
CHD1 deletion
|
Prostate Cancer
|
AST-2970 Sensitive: C3 – Early Trials
|
AST-2970 Sensitive: C3 – Early Trials
|
CHD1 deletion
|
Prostate Cancer
|
CHD1 deletion
|
Prostate Cancer
|
abiraterone acetate Resistant: C3 – Early Trials
|
abiraterone acetate Resistant: C3 – Early Trials
|
CHD1 deletion
|
Prostate Cancer
|
CHD1 deletion
|
Prostate Cancer
|
enzalutamide capsule Resistant: C3 – Early Trials
|
enzalutamide capsule Resistant: C3 – Early Trials
|